Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients.
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Impaired Object Handling during Bimanual Task Performance in Multiple Sclerosis.
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
PML risk stratification using anti-JCV antibody index and L-selectin.
The induction of Treg cells by gut-indigenous Clostridium.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Multiple Sclerosis in Gulf War Era Veterans. 2. Military Deployment and Risk of Multiple Sclerosis in the First Gulf War.
Dimethyl fumarate - only an anti-psoriatic medication?
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
[Charcot and his legacy to medicine].
The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review.
[Optic neuropathy after retrobulbar neuritis in multiple sclerosis : Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?].
Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
AMPYRA® two-year safety data presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Alemtuzumab for multiple sclerosis: who and when to treat?
Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Contribution of MicroRNAs to autoimmune diseases.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.

Pages